An ADME study of [14C]AZD0780 in Healthy Male Subjects

Trial Identifier: D7960C00004
Sponsor: AstraZeneca
Collaborator:
Quotient Sciences Limited
Start Date: April 2023
Primary Completion Date: June 2023
Study Completion Date: June 2023
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
GB Ruddington, GB, NG11 6JS